PHGDH and glioblastoma: Meanwhile, a recent study implicated phosphoglycerate dehydrogenase (PHGDH) metabolism in endothelial cells as a driver of vascular dysfunction in GBM.76 PHGDH inhibition sensitized murine GBM models to EGFRvIII-CAR-T therapy, which led to improved survival and T-cell persistence.